Nitric Oxide Inhibits Hepatitis B Virus Replication in the Livers of Transgenic Mice
暂无分享,去创建一个
[1] F. Chisari,et al. Relative Sensitivity of Hepatitis B Virus and Other Hepatotropic Viruses to the Antiviral Effects of Cytokines , 2000, Journal of Virology.
[2] F. Chisari,et al. Cytokine-induced viral purging--role in viral pathogenesis. , 1999, Current opinion in microbiology.
[3] M. Shapiro,et al. Viral clearance without destruction of infected cells during acute HBV infection. , 1999, Science.
[4] F. Chisari,et al. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. , 1998, Journal of immunology.
[5] T. Komatsu,et al. Does Nitric Oxide Play a Critical Role in Viral Infections? , 1998, Journal of Virology.
[6] P. Kubes,et al. Inducible nitric oxide synthase‐deficient mice have enhanced leukocyte–endothelium interactions in endotoxemia , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] F. Chisari,et al. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice , 1997, Journal of virology.
[8] P. Kubes,et al. Role of nitric oxide in regulation of leucocyte‐endothelial cell interactions , 1997, Experimental physiology.
[9] F. Chisari,et al. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[10] F. Chisari,et al. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. , 1996, Immunity.
[11] E. Borden,et al. An overview of the interferon system: signal transduction and mechanisms of action. , 1996, Cancer investigation.
[12] F. Chisari,et al. High-level hepatitis B virus replication in transgenic mice , 1995, Journal of virology.
[13] C. Nathan,et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase , 1995, Cell.
[14] P. Kubes,et al. Nitric oxide is an antiadhesive molecule for leukocytes. , 1995, New horizons.
[15] C. Chiang,et al. Expression of the inducible nitric oxide synthase. Correlation with neuropathology and clinical features in mice with lymphocytic choriomeningitis. , 1994, Journal of immunology.
[16] M Aguet,et al. Functional role of type I and type II interferons in antiviral defense. , 1994, Science.
[17] R. Zinkernagel,et al. Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon , 1994, Journal of virology.
[18] C. Lowenstein,et al. Nitric Oxide: A Physiologic Messenger , 1994, Annals of Internal Medicine.
[19] F. Chisari,et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis , 1993, The Journal of experimental medicine.
[20] H. Lother,et al. Mechanism of recovery from acute virus infection. VIII. Treatment of lymphocytic choriomeningitis virus‐infected mice with anti‐interferon‐γ monoclonal antibody blocks generation of virus‐specific cytotoxic T lymphocytes and virus elimination , 1989, European journal of immunology.
[21] R. Zinkernagel,et al. Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice , 1989, Journal of virology.